SUN PHARMACEUTICAL INDUSTRIES INC recalls Gabapentin Capsules, USP 300 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-138-05; b) 1000-count bottles, ND
Recalled April 16, 2025 · FDA recall D-0311-2025 · SUN PHARMACEUTICAL INDUSTRIES
Hazard
Cross Contamination · FDA Class III
Units
12,876 bottles
Sold at
Nationwide in the USA
Description
Cross Contamination
Product
Gabapentin Capsules, USP 300 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-138-05; b) 1000-count bottles, NDC 62756-138-04, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India.
Manufacturer(s)
SUN PHARMACEUTICAL INDUSTRIES INC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →